✦ LIBER ✦

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

✍ Scribed by Francesca De Amicis; Janagi Thirugnansampanthan; Yukun Cui; Jennifer Selever; Amanda Beyer; Irma Parra; Nancy L. Weigel; Matthew H. Herynk; Anna Tsimelzon; Michael T. Lewis; Gary C. Chamness; Susan G. Hilsenbeck; Sebastiano Andò; Suzanne A. W. Fuqua

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 393 KB
Volume: 121
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0436-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased expression of enolase α in hum

Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells

✍ Shih-Hsin Tu; Chih-Chiang Chang; Ching-Shyang Chen; Ka-Wai Tam; Ying-Jan Wang; C 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 955 KB

Survivin plays as a resistant factor aga

Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells

✍ Ryosuke Moriai; Naoki Tsuji; Mikako Moriai; Daisuke Kobayashi; Naoki Watanabe 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 610 KB

Androgen receptors in endocrine-therapy-

Androgen receptors in endocrine-therapy-resistant human prostate cancer

✍ Theodorus H. van der Kwast; Jack Schalken; Jacobus A. Ruizeveld de Winter; J. Co 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 824 KB

Despite the initial androgen-dependent growth of most human prostate cancers, eventually all prostate cancers become androgen-independent at varying intervals after androgen ablation or anti-androgen therapy. In order to gain more insight into the role of the androgen receptor (AR) in this process,

Androgens, progestins and tamoxifen indu

Androgens, progestins and tamoxifen induce PSA production in the breast cancer cell line T-47D

✍ E.P. Diamandis; Y. He; L. Grass 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 124 KB

## CHEMISTS 2h to complete, is precise (CV's<I0%) and highly sensitive, with a detection limit of <0.05 pg/L. Comparison with an enzymatic CK-BB assay for 166 breast tumor cytosols (determination of CK-B subunit after immunoinhibition of CK-M subunit) gave the following equation: y (TR-FIA method)

HER2 overexpression and activation, and

HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer

✍ Christian F. Singer; Daphne Gschwantler-Kaulich; Anneliese Fink-Retter; Georg Pf 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 362 KB

Modulation of induced resistance to adri

Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleate

✍ Brenda J. Foster; Karen R. Grotzinger; Wilma M. McKoy; Lawrence V. Rubinstein; T 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 602 KB

The clinical utility of adriamycin in the treatment of patients with metastatic breast cancer is often-limited by the development of drug resistance. It has been recognized that in addition to the development of primary resistance against adriamycin, malignant cells can simultaneously develop cross-